Skip to main content

Muscle Relaxer Misuse: Is Tizanidine a Narcotic, Is Flexeril Addictive, and Overdose Risks

Most muscle relaxers are not narcotics or controlled substances; carisoprodol (Soma) is the exception, a Schedule IV drug with known abuse and withdrawal. All of them add to the sedation of alcohol, opioids and benzodiazepines, and stopping some suddenly, especially baclofen and tizanidine, can be dangerous. Taper with the prescriber.

Updated First published 6 sourcesLeer en español

Published by DetoxNJ.comHow we check facts

When a muscle relaxer is an emergency

Call 911 for any of these, especially after mixing a muscle relaxer with alcohol, opioids or benzodiazepines:

  • A seizure
  • Hallucinations or severe confusion
  • A very slow or irregular heartbeat
  • Fainting
  • A person who is very hard to wake or breathing slowly

If the person will not wake or is breathing slowly, treat it as an opioid overdose, even if no one thinks opioids were used:

  1. Give naloxone (Narcan) if you have it.
  2. If they do not wake up, give another dose every 2 to 3 minutes, as the package directs.
  3. Lay them on their side.
  4. Stay until help arrives.

Poison Control is 1-800-222-1222.

New Jersey’s Overdose Prevention Act protects both a caller who seeks medical help in good faith and the person who overdosed from arrest, charges, prosecution and conviction for simple possession, use and paraphernalia offenses when the evidence comes from seeking that help. It does not cover selling.

For a mental health or suicidal crisis, call or text 988.

Which muscle relaxers are controlled substances

Only one common muscle relaxer is federally controlled. The rest are prescription drugs without a DEA schedule, but “not controlled” does not mean harmless, as the table shows. Half-lives are from each drug’s FDA label.

Drug (brand)Controlled?Misuse and dependenceStopping suddenlyHalf-life
Carisoprodol (Soma)Yes, Schedule IV since January 11, 2012Abuse, dependence and withdrawal reported; turns into meprobamate, itself a controlled sedativeInsomnia, vomiting, cramps, headache, tremor, twitching, unsteadiness, hallucinations, psychosisAbout 2 hours (meprobamate about 10)
Tizanidine (Zanaflex)NoLabel says abuse potential was not evaluated in humans; strongly sedating and lowers blood pressureRebound high blood pressure, fast heart rate, muscle stiffness, especially after high doses for 9 weeks or moreAbout 2.5 hours
BaclofenNoSedating; adds to other depressantsHallucinations and seizures reported on abrupt withdrawalNot stated here; label advises a slow taper
Cyclobenzaprine (generic of Flexeril)NoLabel: stopping rarely causes nausea, headache and malaise, which are “not indicative of addiction”Usually mild, per labelAbout 18 hours (range 8 to 37)

Is tizanidine a narcotic?

No. The tizanidine label states it is not a controlled substance, and it is not an opioid. It works like clonidine, on alpha-2 receptors, which is why it can drop blood pressure and cause heavy drowsiness. It should not be combined with fluvoxamine or ciprofloxacin, which can push blood levels high enough to cause dangerously low blood pressure, and the label calls for liver tests because it can injure the liver.

How long does tizanidine stay in your system?

Tizanidine itself has a half-life of about 2.5 hours, so most of it is gone within about half a day. Its metabolites, which the label says are not known to be active, have half-lives of 20 to 40 hours.

Is tizanidine addictive, and what happens if you stop?

The label says abuse potential was not studied in people. The clearer risk is stopping suddenly: rebound high blood pressure, fast heart rate and stiff muscles. The label calls for decreasing the dose slowly, especially after 20 to 28 mg a day for nine weeks or more, or when it is taken with opioids.

Is Flexeril addictive, and why was it discontinued?

Flexeril is the old brand name for cyclobenzaprine. The brand tablets are listed as discontinued in the FDA’s Drugs@FDA database, with a Federal Register determination that they were not withdrawn for safety or effectiveness reasons. Generic cyclobenzaprine is still sold and widely prescribed.

It is not a controlled substance, and its label says that stopping after long use rarely causes nausea, headache and malaise, and that these are not signs of addiction. The real dangers are chemical. Cyclobenzaprine is a close relative of tricyclic antidepressants, can cause serotonin syndrome with SSRIs, SNRIs, tramadol, bupropion and MAO inhibitors, and the label says deaths, though rare, can follow overdose, with other drugs or alcohol often involved.

Carisoprodol (Soma): the one that is controlled

The DEA placed carisoprodol in Schedule IV, effective January 11, 2012. Its label describes abuse, misuse and diversion; abuse can lead to overdose, slowed breathing, low blood pressure, seizures and death. Stopping suddenly after long use has caused insomnia, vomiting, cramps, headache, tremor, muscle twitching, unsteadiness, hallucinations and psychosis. The body converts carisoprodol to meprobamate, a controlled sedative that can cause dependence on its own.

Baclofen: do not stop it suddenly

Baclofen is not controlled, but its label warns that hallucinations and seizures have occurred on abrupt withdrawal and that, except for serious side effects, the dose should be reduced slowly when the drug is stopped. Running out of baclofen is a reason to call the prescriber the same day, not to wait.

Can you overdose on muscle relaxers?

Yes. Carisoprodol and cyclobenzaprine labels both describe deaths from overdose, and every drug in this group adds to the sedation of alcohol, opioids, benzodiazepines and sleep medicines. The combinations are where most of the danger is: a muscle relaxer with an opioid or a benzodiazepine can slow breathing more than either alone. If a muscle relaxer is being taken for its effect, mixed with other drugs, or hard to stop, that is a reason for an assessment; our signs you need detox guide helps sort it out, and the list of licensed detox programs in New Jersey shows where to go.

In New Jersey

Fully insured New Jersey plans and the State Health Benefits and School Employees’ plans cannot require prior authorization for the first 180 days per plan year of in-network treatment your own physician, psychologist or psychiatrist finds medically necessary. Self-funded employer plans, Medicare and Medicaid are not covered by that rule. NJ FamilyCare (Medicaid) members and people without insurance can call the IME Addictions Access Center at 1-844-276-2777, which screens callers and refers them to treatment. ReachNJ, at 1-844-732-2465, is the state’s treatment referral line. Both answer 24/7. Same-day admission is sometimes possible; it is not guaranteed. For what a specific plan covers, see the insurance guides.

Periscope Behavioral Health, which publishes this site, is opening a medical detox in Hammonton, Atlantic County, expected Summer 2027. Until then, the admissions line of our publisher, Periscope Behavioral Health, at (888) 313-3583, can talk through options in New Jersey and Florida, including facilities Periscope operates. What a plan covers depends on the plan and the facility’s network status.

Need help finding detox? Call the admissions line of our publisher, Periscope Behavioral Health: (888) 313-3583. Your call is treated confidentially, and insurance questions are welcome. Free state lines, 24/7: ReachNJ 1-844-732-2465 · NJ IME Addictions Access Center (Medicaid and uninsured) 1-844-276-2777.

Frequently asked

Is tizanidine a controlled substance?

No. The FDA label states that tizanidine is not a controlled substance, and it is not an opioid. It can still cause heavy sedation and low blood pressure, and stopping high doses suddenly can cause rebound high blood pressure and a fast heart rate.

Is cyclobenzaprine a narcotic?

No. Cyclobenzaprine (the generic of Flexeril) is not a controlled substance or an opioid. It is chemically related to tricyclic antidepressants and can cause serotonin syndrome when combined with SSRIs, SNRIs, tramadol and some other drugs.

Which muscle relaxer is a controlled substance?

Carisoprodol (Soma), in federal Schedule IV since January 11, 2012. The body converts it to meprobamate, another controlled sedative.

Is Flexeril still available?

The Flexeril brand is listed as discontinued in the FDA's Drugs@FDA database, with a Federal Register determination that it was not withdrawn for safety or effectiveness reasons. Generic cyclobenzaprine is still available.

Can you mix muscle relaxers with alcohol or opioids?

It is risky. Muscle relaxers add to the sedating and breathing effects of alcohol, opioids, benzodiazepines and sleep medicines. Ask the prescriber or pharmacist before combining them.

Is it dangerous to stop baclofen suddenly?

Yes. The baclofen label warns that hallucinations and seizures have occurred on abrupt withdrawal and that the dose should be reduced slowly. Do not run out or stop on your own.

Request confidential help — 24/7, no obligation.

Prefer to call our publisher's admissions line, Periscope Behavioral Health?

(888) 313-3583

Free state lines, 24/7: ReachNJ 1-844-732-2465 · NJ IME Addictions Access Center (Medicaid and uninsured) 1-844-276-2777

Tell us about your situation and a DetoxNJ care navigator will reach out. DetoxNJ is published by Periscope Behavioral Health, which operates or holds an ownership interest in Emerald Wellness, South Jersey Recovery Program, Palm Beach Recovery Centers, Palm Beach Healing Centers, and Transitions Recovery Program, and is developing a medical detox in Hammonton, NJ (expected Summer 2027). We make an introduction only if you ask us to.

Sources (6)

  1. Tizanidine tablets, FDA prescribing information (DailyMed, 2026).
  2. Cyclobenzaprine hydrochloride tablets, FDA prescribing information (DailyMed, 2026).
  3. Carisoprodol tablets, FDA prescribing information (DailyMed, 2026).
  4. Baclofen tablets, FDA prescribing information (DailyMed, 2026).
  5. Drugs@FDA: Flexeril (NDA 017821), marketing status.
  6. DEA. Placement of Carisoprodol Into Schedule IV. Final rule, 76 FR 77330, December 12, 2011.